Profile data is unavailable for this security.
About the company
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
- Revenue in DKK (TTM)17.18bn
- Net income in DKK4.00bn
- Incorporated1957
- Employees12.00k
- LocationColoplast A/SHoltedam 1-3HUMLEBAEK 3050DenmarkDNK
- Phone+45 49111111
- Fax+45 49111555
- Websitehttps://www.coloplast.dk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amplifon SpA | 11.44bn | 804.56m | 37.65bn | 10.77k | 46.67 | 8.09 | 21.34 | 3.29 | 0.4778 | 0.4778 | 6.82 | 2.76 | 0.6879 | 22.72 | 9.40 | 142,560.50 | 4.84 | 5.03 | 6.86 | 6.62 | 19.81 | 56.61 | 7.03 | 6.29 | 0.5951 | 17.89 | 0.69 | 25.34 | 7.60 | 10.49 | -0.1342 | 50.87 | 18.64 | 26.63 |
| GN Store Nord A/S | 11.15bn | 1.29bn | 42.77bn | 6.18k | 31.62 | 8.13 | 21.03 | 3.84 | 9.51 | 9.51 | 82.39 | 36.98 | 0.8802 | 5.14 | 5.26 | 1,850,788.00 | 10.23 | 8.77 | 13.79 | 10.97 | 61.90 | 62.06 | 11.62 | 11.37 | 0.6577 | 9.27 | 0.5275 | 17.42 | 10.66 | 9.33 | 10.61 | 11.04 | 5.54 | 9.95 |
| Demant A/S | 14.51bn | 1.70bn | 50.38bn | 15.04k | 29.80 | 6.61 | 20.97 | 3.47 | 6.89 | 6.89 | 59.04 | 31.09 | 0.764 | 1.96 | 4.87 | 1,018,246.00 | 8.97 | 10.93 | 16.16 | 17.94 | 77.98 | 75.45 | 11.74 | 13.22 | 0.5028 | 25.53 | 0.5477 | 0.00 | 5.67 | 9.24 | 3.93 | 7.24 | 1.21 | -- |
| Straumann Holding AG | 9.37bn | 1.87bn | 85.64bn | 5.95k | 45.69 | 10.35 | 37.75 | 9.14 | 17.18 | 17.18 | 85.86 | 75.85 | 0.7657 | 2.06 | 5.05 | 229,015.80 | 15.60 | 15.83 | 18.08 | 18.33 | 74.75 | 76.72 | 20.37 | 20.79 | 2.14 | 12.72 | 0.1556 | 34.12 | 22.61 | 14.93 | -2.42 | 21.93 | 54.05 | 6.96 |
| Sartorius Stedim Biotech SA | 9.50bn | 1.66bn | 92.38bn | 5.80k | 55.37 | 11.84 | 42.90 | 9.72 | 2.43 | 2.43 | 13.85 | 11.36 | 0.8173 | 2.60 | 5.56 | 225,998.20 | 14.44 | 12.47 | 19.59 | 16.59 | 51.78 | 50.89 | 17.67 | 14.71 | 0.7264 | 17.98 | 0.116 | 25.85 | 12.13 | 15.55 | 29.15 | 25.71 | 43.24 | 23.30 |
| Sonova Holding AG | 18.99bn | 3.12bn | 100.61bn | 14.74k | 32.22 | 6.22 | 24.91 | 5.30 | 6.96 | 6.96 | 42.29 | 36.03 | 0.643 | 2.92 | 5.70 | 187,462.70 | 10.71 | 11.32 | 13.67 | 14.01 | 71.16 | 69.25 | 16.65 | 16.27 | 0.9997 | 81.24 | 0.2093 | 41.08 | 4.43 | 7.21 | 13.49 | 5.91 | 4.49 | 8.83 |
| Smith & Nephew plc | 33.46bn | 4.72bn | 135.57bn | 16.38k | 28.76 | 4.05 | 17.39 | 4.05 | 0.6597 | 0.6597 | 4.68 | 4.68 | 0.5942 | 0.8967 | 3.98 | 250,076.00 | 8.38 | 8.62 | 10.02 | 10.47 | 73.87 | 74.21 | 14.10 | 13.38 | 0.9613 | 15.19 | 0.3056 | 45.33 | 2.92 | 2.42 | -17.02 | 3.58 | 0.4084 | 5.19 |
| Coloplast A/S | 17.18bn | 4.00bn | 162.95bn | 12.00k | 43.73 | 28.33 | 35.21 | 9.48 | 18.82 | 18.82 | 80.86 | 29.05 | 1.37 | 3.17 | 5.72 | 1,485,090.00 | 31.94 | 25.63 | 62.05 | 43.18 | 67.31 | 68.14 | 23.28 | 19.28 | 0.7754 | 54.83 | 0.3027 | 103.06 | 5.93 | 7.17 | 1.26 | 7.24 | 8.74 | 9.86 |
| Siemens Healthineers AG | 104.99bn | 10.70bn | 263.60bn | 50.30k | 24.59 | 3.96 | 17.29 | 2.51 | 1.44 | 1.44 | 14.11 | 8.92 | 0.7128 | 4.12 | 4.63 | 281,600.00 | 7.35 | -- | 10.14 | -- | 40.27 | -- | 10.31 | -- | 0.9292 | 19.93 | 0.0186 | -- | -1.81 | -- | -8.27 | -- | -- | -- |
| Koninklijke Philips NV | 139.55bn | 10.83bn | 281.15bn | 77.75k | 26.77 | 3.16 | 16.46 | 2.01 | 1.56 | 1.47 | 20.10 | 13.19 | 0.7314 | 3.50 | 5.14 | 241,783.00 | 5.71 | 2.44 | 7.92 | 3.56 | 46.88 | 43.80 | 7.80 | 3.81 | 0.855 | 18.75 | 0.3278 | 114.41 | 1.92 | -3.80 | 60.07 | 4.79 | -0.3289 | 1.22 |
| EssilorLuxottica SA | 111.90bn | 9.19bn | 413.77bn | 150.62k | 39.49 | 1.65 | 18.97 | 3.70 | 3.22 | 3.22 | 42.55 | 77.25 | 0.495 | 3.53 | 6.76 | -- | 4.45 | 6.61 | 5.43 | 8.71 | 61.15 | 60.75 | 9.00 | 12.35 | 0.7337 | 20.52 | 0.1128 | 40.85 | 17.58 | 16.35 | 4.52 | 12.88 | 19.04 | 16.76 |
Data as of Aug 16 2019. Currency figures normalised to Coloplast A/S's reporting currency: Danish Krone DKK
11.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Jul 2019 | 3.70m | 1.87% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2019 | 2.58m | 1.30% |
| Norges Bank Investment Managementas of 31 Dec 2018 | 2.50m | 1.26% |
| Allianz Global Investors GmbHas of 15 Aug 2019 | 2.45m | 1.24% |
| Comgest SAas of 30 Apr 2019 | 2.17m | 1.10% |
| Fundsmith LLPas of 30 Jun 2018 | 2.13m | 1.07% |
| Jupiter Asset Management Ltd.as of 31 Mar 2019 | 1.94m | 0.98% |
| BlackRock Fund Advisorsas of 08 Aug 2019 | 1.84m | 0.93% |
| Capital Research & Management Co. (Global Investors)as of 30 Jun 2019 | 1.46m | 0.74% |
| Walter Scott & Partners Ltd.as of 28 Jun 2019 | 1.03m | 0.52% |
More ▼
Data from 31 Dec 2018 - 30 Jun 2019Source: FactSet Research Systems Inc.
